-
Loading metrics
Semaglutide combined with empagliflozin vs. monotherapy for non-alcoholic fatty liver disease in type 2 diabetes: Study protocol for a randomized clinical trial
- Yu-Hao Lin,
- Zhi-Jun Zhang,
- Jin-Qing Zhong,
- Zhi-Yi Wang,
- Yi-Ting Peng,
- Yan-Mei Lin,
- Huo-Ping Zhang,
- Jian-Qing Tian
x
- Published: May 3, 2024
- https://doi.org/10.1371/journal.pone.0302155